Trials / Completed
CompletedNCT01727297
REVEAL AF: Incidence of AF in High Risk Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 446 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to determine, through continuous monitoring with the Reveal implantable cardiac monitor (ICM), the incidence of atrial fibrillation (AF) in patients suspected to be at high risk for having AF and to understand how physicians manage these patients after AF has been detected. This study will also seek to identify what patient characteristics are most predictive of developing AF.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | REVEAL Implantable Cardiac Monitor |
Timeline
- Start date
- 2012-11-13
- Primary completion
- 2017-01-13
- Completion
- 2017-01-30
- First posted
- 2012-11-15
- Last updated
- 2018-04-30
- Results posted
- 2018-03-29
Locations
58 sites across 7 countries: United States, Austria, Germany, Italy, Netherlands, Slovenia, Spain
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01727297. Inclusion in this directory is not an endorsement.